检索结果 - Momtaz, Parisa
- Showing 1 - 20 results of 20
-
1
-
2
-
3
Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience 由 Page, David B, Naidoo, Jarushka, Momtaz, Parisa, Bogatch, Kita, Kuk, Deborah, Panageas, Katherine, Yuan, Jianda, Wolchok, Jedd D, Postow, Michael
出版 2014Text -
4
Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAF(V600) mutated malignancies 由 Momtaz, Parisa, Pentsova, Elena, Abdel-Wahab, Omar, Diamond, Eli, Hyman, David, Merghoub, Taha, You, Daoqi, Gasmi, Billel, Viale, Agnes, Chapman, Paul B.
出版 2016Text -
5
Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma 由 Shoushtari, Alexander N., Friedman, Claire F., Navid-Azarbaijani, Pedram, Postow, Michael A., Callahan, Margaret K., Momtaz, Parisa, Panageas, Katherine S., Wolchok, Jedd D., Chapman, Paul B.
出版 2017Text -
6
Checkpoint blockade in melanoma patients with underlying chronic lymphocytic leukemia 由 Smithy, James W., Pianko, Matthew J., Maher, Colleen, Postow, Michael A., Shoushtari, Alexander N., Momtaz, Parisa, Chapman, Paul B., Wolchok, Jedd D., Park, Jae H., Callahan, Margaret K.
出版 2021Text -
7
Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab 由 Friedman, Claire F., Clark, Varina, Raikhel, Andrew V., Barz, Tim, Shoushtari, Alexander N., Momtaz, Parisa, Callahan, Margaret K., Wolchok, Jedd D., Chapman, Paul B., Hellmann, Matthew D., Postow, Michael A.
出版 2017Text -
8
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation 由 Momtaz, Parisa, Harding, James J., Ariyan, Charlotte, Coit, Daniel G., Merghoub, Taha, Gasmi, Billel, You, Daoqi, Viale, Agnes, Panageas, Katherine S., Samoila, Aliaksandra, Postow, Michael A., Wolchok, Jedd D., Chapman, Paul B.
出版 2017Text -
9
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade 由 Bello, Danielle M., Panageas, Katherine S., Hollmann, Travis, Shoushtari, Alexander N., Momtaz, Parisa, Chapman, Paul B., Postow, Michael A., Callahan, Margaret K., Wolchok, Jedd D., Brady, Mary S., Coit, Daniel G., Ariyan, Charlotte E.
出版 2019Text -
10
Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade 由 Betof Warner, Allison, Palmer, Jessica S., Shoushtari, Alexander N., Goldman, Debra A., Panageas, Katherine S., Hayes, Sara A., Bajwa, Raazi, Momtaz, Parisa, Callahan, Margaret K., Wolchok, Jedd D., Postow, Michael A., Chapman, Paul B.
出版 2020Text -
11
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis 由 Kuk, Deborah, Shoushtari, Alexander N., Barker, Christopher A., Panageas, Katherine S., Munhoz, Rodrigo R., Momtaz, Parisa, Ariyan, Charlotte E., Brady, Mary Sue, Coit, Daniel G., Bogatch, Kita, Callahan, Margaret K., Wolchok, Jedd D., Carvajal, Richard D., Postow, Michael A.
出版 2016Text -
12
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memor... 由 Horvat, Troy Z., Adel, Nelly G., Dang, Thu-Oanh, Momtaz, Parisa, Postow, Michael A., Callahan, Margaret K., Carvajal, Richard D., Dickson, Mark A., D'Angelo, Sandra P., Woo, Kaitlin M., Panageas, Katherine S., Wolchok, Jedd D., Chapman, Paul B.
出版 2015Text -
13
PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma 由 Catalanotti, Federica, Cheng, Donavan T., Shoushtari, Alexander N., Johnson, Douglas B., Panageas, Katherine S., Momtaz, Parisa, Higham, Catherine, Won, Helen H., Harding, James J., Merghoub, Taha, Rosen, Neal, Sosman, Jeffrey A., Berger, Michael F., Chapman, Paul B., Solit, David B.
出版 2017Text -
14
Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study) 由 Postow, Michael A., Goldman, Debra A., Shoushtari, Alexander N., Betof Warner, Allison, Callahan, Margaret K., Momtaz, Parisa, Smithy, James W., Naito, Ellesa, Cugliari, Marina K., Raber, Vladislav, Eton, Omar, Nair, Suresh G., Panageas, Katherine S., Wolchok, Jedd D., Chapman, Paul B.
出版 2022Text -
15
Therapeutic Implications of Detecting MAP Kinase Activating Alterations in Cutaneous and Unknown Primary Melanomas 由 Shoushtari, Alexander N., Chatila, Walid K., Arora, Arshi, Sanchez-Vega, Francisco, Kantheti, Havish, Zamalloa, Jorge Rojas, Krieger, Penina, Callahan, Margaret K., Warner, Allison Betof, Postow, Michael A., Momtaz, Parisa, Nair, Suresh, Ariyan, Charlotte, Barker, Christopher, Brady, Mary Susan, Coit, Daniel, Rosen, Neal, Chapman, Paul B., Busam, Klaus, Solit, David B., Panageas, Katherine S., Wolchok, Jedd D., Schultz, Nikolaus
出版 2021Text -
16
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade. 由 Shen, Ronglai, Postow, Michael A., Adamow, Matthew, Arora, Arshi, Hannum, Margaret, Maher, Colleen, Wong, Phillip, Curran, Michael A., Hollmann, Travis J., Jia, Liwei, Al-Ahmadie, Hikmat, Keegan, Niamh, Funt, Samuel A., Iyer, Gopa, Rosenberg, Jonathan E., Bajorin, Dean F., Chapman, Paul B., Shoushtari, Alexander N., Betof, Allison S., Momtaz, Parisa, Merghoub, Taha, Wolchok, Jedd D., Panageas, Katherine S., Callahan, Margaret K.
出版 2021Text -
17
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma 由 Postow, Michael A., Knox, Susan J., Goldman, Debra A., Elhanati, Yuval, Mavinkurve, Vikram, Wong, Phillip, Halpenny, Darragh, Reddy, Sunil K., Vado, Kenya, McCabe, Danielle, Aufiero Ramirez, Kristen, Macri, Mary, Schwarzenberger, Paul, Ricciardi, Toni, Ryan, Aileen, Venhaus, Ralph, Momtaz, Parisa, Shoushtari, Alexander N., Callahan, Margaret K., Chapman, Paul B., Wolchok, Jedd D., Subrahmanyam, Priyanka B., Maecker, Holden T., Panageas, Katherine S., Barker, Christopher A.
出版 2020Text -
18
First-line pembrolizumab and trastuzumab in HER2-positive esophagogastric cancer 由 Janjigian, Yelena Y., Maron, Steven B., Chatila, Walid K., Millang, Brittanie, Chavan, Shweta S., Alterman, Carly, Chou, Joanne F., Simmons, Marc, Momtaz, Parisa, Shcherba, Marina, Ku, Geoffrey Y., Zervoudakis, Alice, Won, Elizabeth S., Kelsen, David P., Ilson, David H., Nagy, Rebecca J., Lanman, Richard B., Ptashkin, Ryan N., Donoghue, Mark T.A., Capanu, Marinela, Taylor, Barry S., Solit, David B., Schultz, Nikolaus, Hechtman, Jaclyn F.
出版 2020Text -
19
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial 由 Richardson, Paul G., Soiffer, Robert J., Antin, Joseph H., Uno, Hajime, Jin, Zhezhen, Kurtzberg, Joanne, Martin, Paul L., Steinbach, Gideon, Murray, Karen F., Vogelsang, Georgia B., Chen, Allen R., Krishnan, Amrita, Kernan, Nancy A., Avigan, David E., Spitzer, Thomas R., Shulman, Howard M., Di Salvo, Donald N., Revta, Carolyn, Warren, Diane, Momtaz, Parisa, Bradwin, Gary, Wei, L. J., Iacobelli, Massimo, McDonald, George B., Guinan, Eva C.
出版 2010Text -
20
Pancreas Cancer and BRCA: A Critical Subset of Patients With Improving Therapeutic Outcomes 由 Momtaz, Parisa, O’Connor, Catherine A., Chou, Joanne F., Capanu, Marinela, Park, Wungki, Bandlamudi, Chaitanya, Berger, Michael F., Kelsen, David P., Suehnholz, Sarah P., Chakravarty, Debyani, Yu, Kenneth H., Varghese, Anna M., Zervoudakis, Alice, Li, Jia, Ku, Geoffrey Y., Park, Jennifer S., Shcherba, Marina, Harding, James J., Goldberg, Zoe, Abou-Alfa, Ghassan K., Salo-Mullen, Erin E., Stadler, Zsofia K., Iacobuzio-Donahue, Christine A., O’Reilly, Eileen M.
出版 2021Text